Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis

NCT05859802 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Dalfampridine Pill
DRUG: Placebo

Sponsor

D'Youville College

Collaborators

[object Object]
[object Object]